Klarity Health Weight Loss: How the Marketplace Connects Care

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

Part of the PlexusDx Education Hub, practical, evidence-based guidance on GLP-1 therapies, weight management protocols, and the genetics shaping every metabolic decision. Browse all Peptides & GLP-1 education.

This is an independent editorial review. PlexusDx has no commercial relationship with Klarity Health or its parent company, and no affiliate links or compensation are involved. Klarity Health is one of many GLP-1 weight-management brands; the sections below describe how its program is organized as of April 2026 without steering you toward a purchase.

Klarity Health as a telehealth marketplace

Unlike a single-clinic model, Klarity Health functions as a marketplace that connects patients with licensed providers. A remote clinical evaluation can lead to a prescription filled at a retail pharmacy for FDA-approved brand products or at a 503A compounding pharmacy for compounded semaglutide or tirzepatide, with follow-up care afterward. The Klarity Health website holds the current program details.

From questionnaire to filled prescription

The path from sign-up to medication follows a familiar arc. You submit a questionnaire covering weight, medical history, and medications. A licensed clinician reviews it and, when eligibility is met, writes a prescription. The order routes to a retail or licensed compounding pharmacy, and telehealth follow-up then supports titration and side-effect management.

What varies across providers

Because this is a marketplace, the provider type (physician, nurse practitioner, or physician assistant), the pharmacy partner (retail or compounded), and the subscription structure can all differ depending on who you are matched with.

Which GLP-1 medications the platform can route

Weight programs in this space generally revolve around GLP-1 receptor agonists such as semaglutide and dual GIP/GLP-1 agonists such as tirzepatide, dispensed as brand-name FDA-approved products or compounded alternatives. The specific option depends on clinical review and the pharmacy network involved.

Eligibility and what the review checks

Eligibility in a marketplace program hinges on the clinical review of your intake, including weight, medical history, and current medications. A provider decides whether a GLP-1 candidate is appropriate and which option fits, so not every applicant is approved and the specific medication is a clinical decision rather than a menu item you select for yourself.

Budgeting for a marketplace program

Published pricing sits on Klarity Health's own site and varies with medication, tier, and whether a product is brand or compounded. Market-wide, typical monthly totals as of April 2026 land between about $200 and $700-plus with wide variance. Confirm current rates on the brand's site before committing, since they change frequently.

Evidence base for the GLP-1 compounds

The clinical weight lives with the compound rather than the storefront. GLP-1 receptor agonists (semaglutide, liraglutide, dulaglutide) and GIP/GLP-1 dual agonists (tirzepatide) form the class. Landmark trials include STEP (semaglutide for weight management, The New England Journal of Medicine, 2021), SURMOUNT (tirzepatide for weight management, NEJM 2022), and SURMOUNT-OSA (tirzepatide for obstructive sleep apnea, NEJM 2024). Populations and endpoints vary, as do individual outcomes.

The upstream biology your intake form skips

A marketplace program does not read the genetics beneath a GLP-1 response. Variants in TCF7L2 (a transcription factor tied to glucose homeostasis and GLP-1 secretion), FTO, GLP1R, and MC4R describe the terrain a clinician prescribes into. These pathway-level signals do not predict response to any particular compound, but they add context the questionnaire never asks about. PlexusDx offers semaglutide and tirzepatide through its Weight Management Protocols - Semaglutide Injection, Semaglutide Oral, Tirzepatide Injection, and Tirzepatide Oral. Before starting, the Precision Peptide Genetic Test analyzes 14 pathways, 49 peptides, 150+ genetic insights, the test-before-you-invest step that turns guesswork into an informed conversation with your provider.

Not affiliated: PlexusDx is not affiliated with Klarity Health and has no commercial relationship with the companies reviewed here.

Related reading on PlexusDx: Bioverse Weight Loss, Direct Meds Weight Loss, Form Health Weight Loss, Ivim Weight Loss.

Frequently Asked Questions

How does the Klarity Health weight-loss marketplace work?

It connects you with a licensed provider who evaluates your intake remotely and, if appropriate, prescribes a GLP-1 medication filled at a retail or 503A compounding pharmacy. Because it is a marketplace, the specific provider and pharmacy can vary, so confirm current details on the brand's own site.

What medications can route through the program?

Weight programs in this category typically center on GLP-1 receptor agonists such as semaglutide and dual agonists such as tirzepatide, offered as brand-name or compounded products. Which option applies depends on the clinical review and the pharmacy network, not on a fixed catalog you select yourself.

How does the Precision Peptide Genetic Test fit a weight-loss program?

It does not predict how you will respond to any program or drug. It reports pathway-level variants in TCF7L2 and FTO, and MC4R that describe your baseline GLP-1 biology, context that stays relevant regardless of which marketplace or clinic writes the prescription.

How does PlexusDx differ from Klarity Health?

PlexusDx pairs its Weight Management Protocols with the Precision Peptide Genetic Test, adding upstream genetic context that marketplace and telehealth-only programs such as Klarity Health do not provide alongside the medication. The distinction is pathway-level insight, not a claim about who delivers care better.

This article is part of the PlexusDx Education Hub. Browse all Peptides & GLP-1 education.

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.